Skip to main content
Premium Trial:

Request an Annual Quote

Michael Young, Julie Barnes

Premium

Michael Young, formerly vice president of commercial development at Genzyme Transgenics, has been appointed to the newly created position of vice president of business development at Reykjavik, Iceland-based DeCode Genetics.

Young will oversee the development of new partnerships for DeCode’s research programs and product offerings in gene discovery, pharmacogenomics, drug and diagnostic development, and database and bioinformatics products and services. BioWisdom of Cambridge, UK, has appointed Julie Barnes as director of life sciences.

Barnes, who was previously head of the department of neuropharmacology research at GlaxoSmithKline (formerly GlaxoWellcome) will lead BioWisdom’s team of life science analysts who position information about public and proprietary drug discovery and development resources within the company’s Discovery Portfolio platform.

She will join the company on June 25.

Filed under

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.